Literature DB >> 35255227

Novel Combined Lidocaine/Povidone Iodine Delivery System for Preintravitreal Injection.

Parissa Ziaei1, Jayde L Resnick1, Nicholas Stella1, Morgan V DiLeo1,2,3,4,5.   

Abstract

Purpose: Intravitreal injection has become a popular treatment for various retina disorders and dramatically increased over the past few years. In traditional preintravitreal injection, the preparation steps are time consuming for practitioners who perform a significant number of injections per day. Besides, lidocaine gel (L-Gel) shows a potential absorption barrier on the antibacterial effect of povidone iodine (PI).
Methods: In this study, we describe a L/PI gel system as an alternative approach to address these issues for traditional preinjection drug administration. Lidocaine and PI are loaded in a thermoresponsive gel instilled as a liquid to the lower fornix that transitions to a stable, solid gel depot. Results and
Conclusion: The gel demonstrated decrease in conjunctival touch sensitivity and sufficient bacteria killing with a single step, suggesting a significant decrease in the time required and less potential for drug inhibition due to sequential administration.

Entities:  

Keywords:  conjunctival touch sensitivity; intravitreal injection; lidocaine; povidone iodine

Mesh:

Substances:

Year:  2022        PMID: 35255227      PMCID: PMC9271332          DOI: 10.1089/jop.2021.0095

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.850


  37 in total

1.  Lidocaine gel anesthesia for intravitreal drug administration.

Authors:  Igor Kozak; Lingyun Cheng; William R Freeman
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

2.  Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis.

Authors:  M G Speaker; F A Milch; M K Shah; W Eisner; B N Kreiswirth
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

3.  Duration of corneal anaesthesia following multiple doses and two concentrations of tetracaine hydrochloride eyedrops on the normal equine cornea.

Authors:  S J Monclin; F Farnir; M Grauwels
Journal:  Equine Vet J       Date:  2011-01       Impact factor: 2.888

4.  Correlation between corneal sensitivity and quantity of reflex tearing in cows, horses, goats, sheep, dogs, cats, rabbits, and guinea pigs.

Authors:  Barbara Wieser; Alexander Tichy; Barbara Nell
Journal:  Vet Ophthalmol       Date:  2012-10-15       Impact factor: 1.644

5.  Effect of topical application of 2% lidocaine gel on corneal sensitivity of clinically normal equine eyes.

Authors:  Alain Regnier; Iris Berton; Didier Concordet; Jean-Yves Douet
Journal:  Vet Anaesth Analg       Date:  2017-09-15       Impact factor: 1.648

6.  A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

Authors:  Geeta A Lalwani; Philip J Rosenfeld; Anne E Fung; Sander R Dubovy; Stephen Michels; William Feuer; Janet L Davis; Harry W Flynn; Maria Esquiabro
Journal:  Am J Ophthalmol       Date:  2009-04-18       Impact factor: 5.258

Review 7.  Endophthalmitis after intravitreal injections.

Authors:  Stephen G Schwartz; Harry W Flynn; Ingrid U Scott
Journal:  Expert Opin Pharmacother       Date:  2009-09       Impact factor: 3.889

8.  Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.

Authors:  Suman Pilli; Athanasios Kotsolis; Richard F Spaide; Jason Slakter; K Bailey Freund; John Sorenson; James Klancnik; Michael Cooney
Journal:  Am J Ophthalmol       Date:  2008-03-10       Impact factor: 5.258

9.  Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.

Authors:  Morgan V Fedorchak; Ian P Conner; Joel S Schuman; Anthony Cugini; Steven R Little
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

10.  A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.

Authors:  William Hollingworth; Tim Jones; Barnaby C Reeves; Tunde Peto
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.